Filtered By:
Drug: Aspirin

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 8741 results found since Jan 2013.

Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry
CONCLUSION: Among hospitalized COVID-19 patients, venous and arterial thromboses differ in timing of presentation, association with COVID-19 severity, and other clinical characteristics.PMID:35230002 | PMC:PMC8895333 | DOI:10.3325/cmj.2022.63.16
Source: Croatian Medical Journal - March 1, 2022 Category: General Medicine Authors: Ivana Jurin Marko Lucijani ć Nevenka Piska č Živković Kristina Lali ć Anamarija Zrili ć Vrkljan Linda Malnar Jane š Ivona Kova čević Tomislav Čikara Anica Sablji ć Nikolina Bu šić Gorana Vukorepa Irzal Had žibegović Ivica Luk šić Bruno Ba Source Type: research

Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study
Conclusion: Pharmaceutical establishments in Colombia seem to have significantly contributed to self-medication for COVID-19 in Colombia during the pandemic. This behavior is inappropriate, since the mild forms of the disease do not have a specific treatment.PLAIN LANGUAGE SUMMARY: Self-medication induced by pharmaceutical establishments in Colombia during the COVID-19 pandemic Background: The COVID-19 pandemic has led to an increase in the behavior of self-medication (SM). Given the massive release of misleading information during the pandemic, some pharmacies recommend drugs such as ivermectin, azithromycin, hydroxychlor...
Source: Adv Data - June 1, 2022 Category: Epidemiology Authors: Maria Jose Nino-Orrego Daniela Baracaldo-Santamar ía Claudia Patricia Ortiz Heyde Patricia Zuluaga Sthefany Alejandra Cruz-Becerra Franklin Soler Andr és M Pérez-Acosta Daniel Ricardo Delgado Carlos-Alberto Calderon-Ospina Source Type: research

Caplacizumab in the successful management of cardiac involvement in thrombotic thrombocytopenic purpura
We report a 76-year-old woman who was admitted for non-ST segment elevation myocardial infarction, left systolic ventricular dysfunction, severe hemolytic anemia, and thrombocytopenia suggestive of TTP (PLASMIC score 7). Therapeutic plasma exchange (TPE) and caplacizumab were started alongside an immunosuppressive regimen. After 3 days of treatment, repeat echocardiography showed complete resolution of left ventricular dysfunction. We were able to stop TPE and start aspirin on the fourth day after normalization of platelet count. Our report outlines the potential benefits of caplacizumab for the time-sensitive management o...
Source: Baylor University Medical Center Proceedings - October 28, 2022 Category: Universities & Medical Training Authors: Amir A Mahmoud Basant Eltaher Anas Hashem Source Type: research